273 related articles for article (PubMed ID: 2543086)
1. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin.
Fuller BB; Niekrasz I; Hoganson GE
Mol Cell Endocrinol; 1990 Aug; 72(2):81-7. PubMed ID: 1704321
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tyrosinase mRNA in mouse melanoma cells by alpha-melanocyte-stimulating hormone.
Rungta D; Corn TD; Fuller BB
J Invest Dermatol; 1996 Nov; 107(5):689-93. PubMed ID: 8875950
[TBL] [Abstract][Full Text] [Related]
5. Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells.
Rauth S; Hoganson GE; Davidson RL
Somat Cell Mol Genet; 1990 Nov; 16(6):583-92. PubMed ID: 2176354
[TBL] [Abstract][Full Text] [Related]
6. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
Slominski A; Moellmann G; Kuklinska E
J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expression.
Kwon BS; Wakulchik M; Haq AK; Halaban R; Kestler D
Biochem Biophys Res Commun; 1988 Jun; 153(3):1301-9. PubMed ID: 3134020
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
Fuller BB; Lunsford JB; Iman DS
J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
[TBL] [Abstract][Full Text] [Related]
9. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
Fuller BB; Lebowitz J
J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tyrosinase activity and protein synthesis in melanoma cells by calcium ionophore A23187.
Fuller BB
Pigment Cell Res; 1987; 1(3):176-80. PubMed ID: 2854256
[TBL] [Abstract][Full Text] [Related]
11. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
Fuller BB; Meyskens FL
J Natl Cancer Inst; 1981 May; 66(5):799-802. PubMed ID: 6262556
[TBL] [Abstract][Full Text] [Related]
12. A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.
Kwon BS; Halaban R; Kim GS; Usack L; Pomerantz S; Haq AK
Mol Biol Med; 1987 Dec; 4(6):339-55. PubMed ID: 2449595
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase activity and abundance in Cloudman melanoma cells.
Halaban R; Pomerantz SH; Marshall S; Lerner AB
Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
[TBL] [Abstract][Full Text] [Related]
14. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells.
Kosano H; Setogawa T; Kobayashi K; Nishigori H
Life Sci; 1995; 56(20):1707-13. PubMed ID: 7723599
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
Fuller BB; Iman DS; Lunsford JB
J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
Thody AJ; Oliver I; Sherbet GV
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
[TBL] [Abstract][Full Text] [Related]
18. Impairment of the melanogenic pathway in B16 melanoma cells transfected with class I H-2 genes.
Prezioso JA; Hearing VJ; Muller J; Urabe K; Wang N; Gorelik E
Melanoma Res; 1995 Feb; 5(1):15-25. PubMed ID: 7734952
[TBL] [Abstract][Full Text] [Related]
19. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage x melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential.
Chakraborty AK; Funasaka Y; Ichihashi M; Sodi S; Bhattacharya M; Pawelek J
Pigment Cell Res; 1999 Dec; 12(6):355-66. PubMed ID: 10614575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
